Literature DB >> 17212660

Role of endocrine and growth factors on the ovarian surface epithelium.

Alice S T Wong1, Peter C K Leung.   

Abstract

Epithelial ovarian cancer is a highly fatal disease for which prevention strategies have been limited; in part because of our poor understanding of the underlying biology of its precursor, the ovarian surface epithelium (OSE). The OSE is a single layer of flat-to-cuboidal mesothelial cells that covers the surface of the ovary. Despite its inconspicuous appearance in vivo, it is believed that OSE cells actively participate in the cyclical ovulatory rupture and repair process. The continuous rupture of the OSE at ovulation and the subsequent proliferation to repair the wound renders the cells susceptible to genetic damage and malignant transformation. As the ovary is a rich source of multiple hormones, and normal OSE and ovarian carcinomas secrete and have receptors for hormones, growth factors and cytokines, these factors are strong candidates to regulate normal OSE physiology and the transformation and progression of ovarian cancers. In particular, alterations of hormone/growth factor production and receptor expression are common in ovarian tumors. This review summarizes the current knowledge in the field of endocrinology and its relationship to the biology and pathology of the OSE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17212660     DOI: 10.1111/j.1447-0756.2007.00478.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  22 in total

Review 1.  The involvement of the Toll-like receptor family in ovulation.

Authors:  Zhilin Liu; Masayuki Shimada; Joanne S Richards
Journal:  J Assist Reprod Genet       Date:  2008-05-29       Impact factor: 3.412

Review 2.  MicroRNA and ovarian cancer.

Authors:  David C Corney; Alexander Yu Nikitin
Journal:  Histol Histopathol       Date:  2008-09       Impact factor: 2.303

3.  Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.

Authors:  Kun-Tu Yeh; Tze-Ho Chen; Hui-Wen Yang; Jian-Liang Chou; Lin-Yu Chen; Chia-Ming Yeh; Yu-Hsin Chen; Ru-Inn Lin; Her-Young Su; Gary C W Chen; Daniel E Deatherage; Yi-Wen Huang; Pearlly S Yan; Huey-Jen Lin; Kenneth P Nephew; Tim H-M Huang; Hung-Cheng Lai; Michael W Y Chan
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528

4.  Expression of FK506 binding protein 65 (FKBP65) is decreased in epithelial ovarian cancer cells compared to benign tumor cells and to ovarian epithelium.

Authors:  Rudi Henriksen; Flemming Brandt Sørensen; Torben Falck Ørntoft; Karin Birkenkamp-Demtroder
Journal:  Tumour Biol       Date:  2011-03-12

5.  Clinicopathological significance of steroidogenic factor-1 expression in ovarian cancer versus ovarian sex cord stromal tumor.

Authors:  Zhuo-ying Hu; Liang-dan Tang; Hong-yu Zhang; Jing-ya Niu; Meng Lou
Journal:  Tumour Biol       Date:  2015-01-22

6.  Ovarian cancer pathogenesis: a model in evolution.

Authors:  Alison M Karst; Ronny Drapkin
Journal:  J Oncol       Date:  2009-09-06       Impact factor: 4.375

7.  Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.

Authors:  Jian-Liang Chou; Her-Young Su; Lin-Yu Chen; Yu-Ping Liao; Corinna Hartman-Frey; Yi-Hui Lai; Hui-Wen Yang; Daniel E Deatherage; Chieh-Ti Kuo; Yi-Wen Huang; Pearlly S Yan; Shu-Huei Hsiao; Chien-Kuo Tai; Huey-Jen L Lin; Ramana V Davuluri; Tai-Kuang Chao; Kenneth P Nephew; Tim H-M Huang; Hung-Cheng Lai; Michael W-Y Chan
Journal:  Lab Invest       Date:  2010-01-11       Impact factor: 5.662

8.  Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer.

Authors:  Michael Wy Chan; Yi-Wen Huang; Corinna Hartman-Frey; Chieh-Ti Kuo; Daniel Deatherage; Huaxia Qin; Alfred Sl Cheng; Pearlly S Yan; Ramana V Davuluri; Tim H-M Huang; Kenneth P Nephew; Huey-Jen L Lin
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

9.  Gene expression patterns in the histopathological classification of epithelial ovarian cancer.

Authors:  Honglan Zhu; Jing Jie Yu
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

10.  Gonadotropins activate oncogenic pathways to enhance proliferation in normal mouse ovarian surface epithelium.

Authors:  Tyvette S Hilliard; Dimple A Modi; Joanna E Burdette
Journal:  Int J Mol Sci       Date:  2013-02-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.